anthropic pbc - ANT
ANT
Close Chg Chg %
83.00 0.00 0.00%
Open Market
83.00
0.00 (0.00%)
Volume: N/A
Last Updated:
Nov 19, 2026, 4:17 AM EDT
Company Overview: anthropic pbc - ANT
ANT Key Data
| Open $83.00 | Day Range N/A - N/A |
| 52 Week Range N/A - N/A | Market Cap N/A |
| Shares Outstanding 190.13M | Public Float N/A |
| Beta N/A | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$9.24 |
| Yield N/A | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME N/A |
ANT Performance
No Data Available
ANT Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
2
Full Ratings ➔
An error occurred while fetching the data.
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Anthropic Pbc - ANT
Collapse All in section
| All values USD millions. | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
Sales/Revenue
| - | 41.00M | 386.00M | 4.58B | |
Sales Growth
| - | - | +841.46% | +1,087.82% | - |
Cost of Goods Sold (COGS) incl D&A
| - | 26.00M | 752.00M | 2.77B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| - | 1.00M | 6.00M | 23.00M | |
Depreciation
| - | 1.00M | 3.00M | 10.00M | |
Amortization of Intangibles
| - | - | 3.00M | 13.00M | - |
COGS Growth
| - | - | +2,792.31% | +268.75% | - |
Gross Income
| - | 15.00M | (366.00M) | 1.81B | |
Gross Income Growth
| - | - | -2,540.00% | +595.08% | - |
Gross Profit Margin
| - | +36.59% | -94.82% | +39.52% |
| 2023 | 2024 | 2025 | 5-year trend | ||
|---|---|---|---|---|---|
SG&A Expense
| - | 566.00M | 2.61B | 8.37B | |
Research & Development
| - | 422.00M | 2.27B | 6.34B | |
Other SG&A
| - | 144.00M | 339.00M | 2.03B | |
SGA Growth
| - | - | +361.84% | +220.28% | - |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | 1.04B | 5.43B | 35.80B | |
EBIT after Unusual Expense
| - | (1.60B) | (8.41B) | (42.37B) | |
Non Operating Income/Expense
| - | 67.00M | 106.00M | 420.00M | |
Non-Operating Interest Income
| - | 69.00M | 106.00M | 431.00M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| - | - | - | - | - |
Interest Expense Growth
| - | - | - | - | - |
Gross Interest Expense
| - | - | - | - | - |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| - | (1.53B) | (8.31B) | (41.95B) | |
Pretax Income Growth
| - | - | -443.36% | -404.87% | - |
Pretax Margin
| - | -3,729.27% | -2,152.33% | -914.83% | |
Income Tax
| - | 2.00M | 1.00M | 20.00M | |
Income Tax - Current - Domestic
| - | - | - | - | - |
Income Tax - Current - Foreign
| - | 2.00M | 4.00M | 17.00M | |
Income Tax - Deferred - Domestic
| - | - | - | - | - |
Income Tax - Deferred - Foreign
| - | - | (3.00M) | 3.00M | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| - | (1.53B) | (8.31B) | (41.97B) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| - | (1.53B) | (8.31B) | (41.97B) | |
Net Income Growth
| - | - | -442.72% | -405.05% | - |
Net Margin Growth
| - | -3,734.15% | -2,152.59% | -915.27% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| - | (1.53B) | (8.31B) | (41.97B) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| - | (1.53B) | (8.31B) | (41.97B) | |
EPS (Basic)
| - | -0.117 | -0.6349 | -3.2067 | |
EPS (Basic) Growth
| - | - | -442.65% | -405.07% | - |
Basic Shares Outstanding
| - | 13.09B | 13.09B | 13.09B | |
EPS (Diluted)
| - | -0.117 | -0.6349 | -3.2067 | |
EPS (Diluted) Growth
| - | - | -442.65% | -405.07% | - |
Diluted Shares Outstanding
| - | 13.09B | 13.09B | 13.09B | |
EBITDA
| - | (550.00M) | (2.97B) | (6.54B) | |
EBITDA Growth
| - | - | -440.73% | -119.80% | - |
EBITDA Margin
| - | -1,341.46% | -770.47% | -142.57% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 100.00 | |
| Number of Ratings | 2 | Current Quarters Estimate | -0.07 | |
| FY Report Date | 12 / 2026 | Current Year's Estimate | 1.083 | |
| Last Quarter’s Earnings | 0.825 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | N/A | Next Fiscal Year Estimate | -0.46 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 2 | 2 | 3 | 3 |
| Mean Estimate | -0.07 | -0.19 | 1.08 | -0.46 |
| High Estimates | -0.02 | -0.04 | 2.48 | 0.21 |
| Low Estimate | -0.12 | -0.34 | 0.33 | -0.96 |
| Coefficient of Variance | -101.02 | -111.65 | 111.77 | -131.14 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | ||
| OVERWEIGHT | 0 | ||
| HOLD | 0 | ||
| UNDERWEIGHT | 0 | ||
| SELL | 0 | ||
| MEAN | Buy |
SEC Filings for Anthropic Pbc - ANT
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
An error occurred while fetching the data.